BAG2 and gastric cancer: Further investigation into the interplay between BAG2 and FGFR signaling in gastric cancer, along with the use of FIIN-2 or the development of more optimized dual-target/selective BAG2 inhibitors, could offer new insights and therapeutic opportunities for targeting apoptosis in gastric cancer cells.